Skip to main content
. 2019 Jul;8(7):2354–2360. doi: 10.4103/jfmpc.jfmpc_331_19

Table 1.

Baseline knowledge of study participants on various aspects of hepatitis B (n=363)

Variable Medical students (n=180) n (%) Nursing students (n=183) n (%) Total (n=363) n (%) P value#
What is hepatitis B
 Identified as viral disease only 71 (39.5) 51 (27.8) 122 (33.6) <0.001
 Identified as liver pathology only 4 (2.2) 25 (13.7) 29 (8.0)
 Both 99 (55.0) 62 (33.9) 161 (44.4)
 Don’t know 0 (0.0) 3 (1.6) 3 (0.8)
 Incorrectly defined 6 (3.3) 42 (23.0) 48 (13.2)
Screening test±
 Correctly answered 136 (75.6) 87 (47.5) 223 (61.4) <0.001
 Incorrectly answered 38 (21.1) 41 (22.4) 79 (21.8)
 Not answered 6 (3.3) 55 (30.1) 61 (16.8)
Diagnostic test£
 Correctly answered 116 (64.5) 8 (4.4) 124 (34.2) <0.001
 Incorrectly answered 47 (26.1) 91 (49.7) 138 (38.0)
 Not answered 17 (9.4) 84 (45.9) 101 (27.8)
Compulsory notification of hepatitis B
 Yes 139 (77.2) 173 (94.5) 312 (86.0) <0.001
 No 32 (17.8) 1 (0.6) 33 (9.1)
 Don’t know 1 (0.6) 0 (0.0) 1 (0.2)
 Not answered 8 (4.4) 9 (4.9) 17 (4.7)
Healthcare worker as a high-risk group
 Yes 177 (98.3) 151 (82.5) 328 (90.4) <0.001
 No 2 (1.1) 13 (7.1) 15 (4.1)
 Not answered 1 (0.6) 19 (10.4) 20 (5.5)
Mandatory screening of blood for hepatitis B at blood banks
 Yes 178 (98.8) 151 (82.5) 329 (90.6) <0.001
 No 1 (0.6) 13 (7.1) 14 (3.9)
 Not answered 1 (0.6) 19 (10.4) 20 (5.5)
Immunization as the best method to eliminate hepatitis B
 Correctly answered 122 (67.8) 84 (45.9) 206 (56.7) <0.001
 Incorrectly answered 51 (28.3) 51 (27.9) 102 (28.1)
 Not answered 7 (3.9) 42 (23.0) 49 (13.5)
 Don’t know 0 (0.0) 6 (3.2) 6 (1.7)
Availability of a vaccine for hepatitis B
 Yes 177 (98.3) 159 (86.9) 336 (92.6) <0.001
 No 3 (1.7) 9 (4.9) 12 (3.3)
 Not answered 0 (0.0) 15 (8.2) 15 (4.1)

±HBsAg HBV-DNA test, #P value calculated either by chi-square or fisher exact test